VXRT Rise in Stock Price On February 2, 2021 and February 3, 2021, the New York Academy of Sciences held a global Symposium, “The Quest for a Covid-19 Vaccine.”
Dr. Antony Fauci, National Institute of Infectious Diseases and Dr. Moncef Slaoui, Operation Warp Speed, were the Key Note Speakers.
Only the leading companies and researchers in the world were invited to participate, such as, Pfizer, Moderna, Novavax and Vaxart. Dr. Sean Tucker, Founder and Chief Scientific Officer of Vaxart was an invited Speaker.
Dr. Orin Levine, Lead Vaccine Delivery, of the Gates Foundation, was also a speaker. Gates has an estimated net worth of $132 billion as of Jan. 2021, according to Bloomberg, while his foundation is investing heavily in Covid-19.
https://www.nyas.org/events/2021/webinar-the-quest-for-a-covid-19-vaccine/
On February 3, 2021, Vaxart issued a press release:
Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate
https://investors.vaxart.com/press-releases
VXRT share price is expected to increase by over 100 percent in 2021 from $9/share to $17/share - $20/share as per The Wall Street Journal.
https://www.wsj.com/market-data/quotes/VXRT/research-ratings